<div id="readability-page-1">04:01 PM EST, 12/04/2025 (MT Newswires) -- Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.9%.The iShares Biotechnology ETF (IBB) eased 0.1%.In corporate news, Humana (HUM) is working with entrepreneur Mark Cuban on a potential pharmacy partnership through Cuban's Cost Plus Drugs venture, Bloomberg reported, citing comments made by Humana's Chief Executive Jim Rechtin at an industry event. Humana shares were down 1.4%.Cross Country Healthcare ( CCRN ) shares fell 20% after it reported Thursday the termination of its merger agreement with Aya Healthcare.Philips (PHG) shares dropped 5% after Reuters reported that executives indicated at an industry event that 2026 organic sales growth is unlikely to double from roughly 2% this year. The company later said it still expects comparative sales growth to accelerate sequentially in 2026 toward mid-single-digit levels, while noting this does not imply doubling growth every single year in its multiyear trajectory.Regentis Biomaterials ( RGNT ) shares fell 11% in their debut on the New York Stock Exchange American after the company priced its initial public offering at $8 a share, raising $10 million in gross proceeds. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

RGNT

休曼納

飛利浦

醫療保健股票下跌，紐約證券交易所醫療保健指數和 XLV 下跌 0.9%。休曼納正在與馬克·庫班的 Cost Plus Drugs 探索藥房合作。Cross Country Healthcare 的股票在與 Aya Healthcare 結束合併後下跌 20%。飛利浦的股票因銷售增長預期温和下跌 5%。Regentis Biomaterials 在紐約證券交易所美國上市，以每股 8 美元籌集了 1000 萬美元

板塊更新：醫療保健類股在下午晚些時候出現下滑